Charles Schwab
AFIB

Charles Schwab’s Acutus Medical Inc AFIB Stock Holding History

Charles Schwab’s Portfolio AFIB Stock Details AFIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-39,813
Closed -$56K – 3676
2022
Q1 		$56K Sell
39,813
-9,308
-19% -$19.9K ﹤0.01% 3514
2021
Q4 		$168K Hold
49,121
– – ﹤0.01% 3382
2021
Q3 		$435K Sell
49,121
-30,146
-38% -$397K ﹤0.01% 3185
2021
Q2 		$1.35M Sell
79,267
-1,308
-2% -$19.1K ﹤0.01% 2831
2021
Q1 		$1.08M Buy
80,575
+12,704
+19% +$286K ﹤0.01% 2830
2020
Q4 		$1.96M Buy
67,871
+3,569
+6% +$96.6K ﹤0.01% 2594
2020
Q3 		$1.92M Buy
+64,302
New +$1.95M ﹤0.01% 2506

Other funds holding AFIB

DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KSCM
Kamunting Street Capital Management Miami Beach, Florida $179M AUM 5.77% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
AFG
American Financial Group Cincinnati, Ohio $284M AUM 12.01% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Charles Schwab's AFIB Position: Q2 2022 in Review

Charles Schwab sold out of Acutus Medical Inc (AFIB) in Q2 2022, closing a stake of 39,813 shares — an estimated $56K sold.

Charles Schwab first reported a position in AFIB in Q3 2020 and held it in 7 quarters. The position peaked at $1.96M in Q4 2020. 47 funds tracked by Wall St. Rank hold AFIB as of Q2 2022.

  • Charles Schwab reported no remaining Acutus Medical Inc position as of Q2 2022 after selling out during the quarter.
  • Charles Schwab sold 39,813 Acutus Medical Inc shares in Q2 2022, an estimated $56K.
  • Charles Schwab first reported a position in Acutus Medical Inc in Q3 2020 and held it in 7 quarters.
  • Charles Schwab's Acutus Medical Inc position peaked at $1.96M in Q4 2020.
  • 47 funds tracked by Wall St. Rank held Acutus Medical Inc as of Q2 2022.

Based on Charles Schwab's 13F filing for Q2 2022, filed 15 Aug 2022.